PABLO
RYAN MÚRUA
Profesor asociado
Fundación Hospital Alcorcón
Alcorcón, EspañaPublicaciones en colaboración con investigadores/as de Fundación Hospital Alcorcón (14)
2024
-
Clinical and Epidemiological Characteristics of the 2022 Mpox Outbreak in Spain (CEME-22 Study)
Open Forum Infectious Diseases, Vol. 11, Núm. 3
2023
-
Patterns of Sexualized Drug Use among Gay, Bisexual, and Other Men Who Have Sex with Men Living with HIV: Insights from a Comprehensive Study—The U-SEX-2 GESIDA 9416 Study
Journal of Clinical Medicine, Vol. 12, Núm. 23
-
Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 76, Núm. 3, pp. e116-e125
2021
-
Hepatocellular carcinoma risk in hepatitis C stage-3 fibrosis after sustained virological response with direct-acting antivirals
Liver International, Vol. 41, Núm. 12, pp. 2885-2891
2020
-
Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)
Scientific Reports, Vol. 10, Núm. 1
2019
-
HIV coinfection predicts failure of ledipasvir/sofosbuvir in treatment-naïve noncirrhotic patients with HCV genotype
Open Forum Infectious Diseases, Vol. 6, Núm. 5
2018
2017
-
Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia
Clinical Microbiology and Infection, Vol. 23, Núm. 1, pp. 49.e1-49.e8
-
Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance
Clinical Microbiology and Infection, Vol. 23, Núm. 9, pp. 672.e1-672.e11
2016
-
Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score–derived analysis of a population-based, multicentre prospective cohort
Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 733.e1-733.e8
2015
-
A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains
Clinical Microbiology and Infection, Vol. 21, Núm. 7, pp. 684.e1-684.e9
-
Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance
Journal of Infection, Vol. 71, Núm. 3, pp. 385-394
-
Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: RESULTS from a population-based surveillance in Spain
Clinical Microbiology and Infection, Vol. 21, Núm. 5, pp. 491.e1-491.e10
2014
-
Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: A population-based surveillance in Spain
Clinical Microbiology and Infection, Vol. 20, Núm. 4